...
机译:蓖麻油的疗效和安全性与脑癌素治疗癌症相关静脉血栓栓塞的疗效和安全性
Division of Vascular DiseasesGonda Vascular CenterRochester MN USA;
Division of Vascular DiseasesGonda Vascular CenterRochester MN USA;
Division of General Internal MedicineMayo ClinicRochester MN USA;
Division of Vascular DiseasesGonda Vascular CenterRochester MN USA;
Division of Vascular DiseasesGonda Vascular CenterRochester MN USA;
Division of Vascular DiseasesGonda Vascular CenterRochester MN USA;
Division of Vascular DiseasesGonda Vascular CenterRochester MN USA;
Division of General Internal MedicineMayo ClinicRochester MN USA;
Division of Vascular DiseasesGonda Vascular CenterRochester MN USA;
Department of Health Sciences ResearchMayo ClinicJacksonville FL USA;
Department of Health Sciences ResearchMayo ClinicJacksonville FL USA;
Department of Health Sciences ResearchMayo ClinicRochester MN USA;
Department of Health Sciences ResearchMayo ClinicRochester MN USA;
Department of Medical OncologyMayo ClinicRochester MN USA;
Division of Vascular DiseasesGonda Vascular CenterRochester MN USA;
cancer; enoxaparin; low molecular weight heparin; rivaroxaban; venous thromboembolism;
机译:蓖麻油的疗效和安全性与脑癌素治疗癌症相关静脉血栓栓塞的疗效和安全性
机译:阿司匹林及氯甲杂交素治疗后对髋部骨折手术后静脉血栓栓塞治疗的疗效和安全性比较
机译:一项随机研究,比较了萘达帕林2850 IU(0.3 mL)与依诺肝素4000 IU(40 mg)在预防结直肠癌术后静脉血栓栓塞中的功效和安全性。
机译:根据不同的复合疗效终点,Fongaparinux优于烯库中的优越性在烯库血栓栓塞中的一致性
机译:可吸入性纳米颗粒在肺癌治疗中的作用;功效,安全性,分布以及纳米颗粒与巨噬细胞的相互作用。
机译:依诺肝素治疗预防髋部骨折术后静脉血栓栓塞的阿司匹林和利伐沙班的疗效和安全性比较
机译:2850 IU(0.3 mL)与麻醉品的安全性相比。依诺肝素4000 IU(40 mg)预防癌症结直肠手术后的静脉血栓栓塞。
机译:抗纤溶机制控制乳腺癌静脉血栓栓塞和转移。